Tapewire

Nasdaq · USD

GENB

Generate Biomedicines, Inc.

Export transactions ↓
Tapewire entity
1553
SEC CIK
0002100782
Parsed reports
34

Last 12 months

Inside the activity.

12 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 2026120
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 26, 2026 Filed Mar 2, 2026 17:47 UTC GrantStock Option (Right to Buy) · Derivative 29,561 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085872 · ownership.xml · derivative · entry 2

Mendillo Jane L · CIK 0001672424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,561

Underlying: Common Stock · 29,561 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 17:58 UTC
Martin SeanChief Legal Officer & GC
GrantStock Option (Right to Buy) · Derivative 190,034 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085910 · ownership.xml · derivative · entry 1

Martin Sean · CIK 0001500332 · Chief Legal Officer & GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,034

Underlying: Common Stock · 190,034 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:50 UTC GrantStock Option (Right to Buy) · Derivative 29,561 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085881 · ownership.xml · derivative · entry 3

Bancel Stephane · CIK 0001443340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,561

Underlying: Common Stock · 29,561 shares

Expires 2036-02-25

F3 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 17:47 UTC GrantStock Option (Right to Buy) · Derivative 29,561 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085871 · ownership.xml · derivative · entry 1

Fanucci Marsha · CIK 0001298814 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,561

Underlying: Common Stock · 29,561 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 17:55 UTC GrantStock Option (Right to Buy) · Derivative 29,561 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085903 · ownership.xml · derivative · entry 1

Simonian Nancy A · CIK 0001359574 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,561

Underlying: Common Stock · 29,561 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 18:09 UTC GrantStock Option (Right to Buy) · Derivative 29,561 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085952 · ownership.xml · derivative · entry 1

Vessey Rupert · CIK 0001677618 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,561

Underlying: Common Stock · 29,561 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 23:02 UTC GrantStock Option (Right to Buy) · Derivative 29,561 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085928 · ownership.xml · derivative · entry 1

ARNOLD FRANCES · CIK 0001665419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,561

Underlying: Common Stock · 29,561 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:50 UTC
Nally MichaelDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 844,595 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085883 · ownership.xml · derivative · entry 5

Nally Michael · CIK 0001763945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 844,595

Underlying: Common Stock · 844,595 shares

Expires 2036-02-25

F4 · derivative.exercise_date: The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:50 UTC
Nally MichaelDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 844,595 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085883 · ownership.xml · derivative · entry 4

Nally Michael · CIK 0001763945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 844,595

Underlying: Common Stock · 844,595 shares

Expires 2036-02-25

F3 · derivative.exercise_date: The shares underlying this option shall vest in two equal installments on each of February 19, 2029 and February 19, 2030, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 23:05 UTC
Grous BethChief People Officer
GrantStock Option (Right to Buy) · Derivative 114,020 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085939 · ownership.xml · derivative · entry 2

Grous Beth · CIK 0002109144 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,020

Underlying: Common Stock · 114,020 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:58 UTC
Lee Laurie AnneChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 42,230 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085911 · ownership.xml · derivative · entry 1

Lee Laurie Anne · CIK 0002112716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,230

Underlying: Common Stock · 42,230 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:54 UTC
Silvers JasonPresident & CFO
GrantStock Option (Right to Buy) · Derivative 274,493 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085898 · ownership.xml · derivative · entry 5

Silvers Jason · CIK 0002109011 · President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,493

Underlying: Common Stock · 274,493 shares

Expires 2036-02-25

F2 · derivative.exercise_date: The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:54 UTC
Silvers JasonPresident & CFO
GrantStock Option (Right to Buy) · Derivative 295,608 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085898 · ownership.xml · derivative · entry 4

Silvers Jason · CIK 0002109011 · President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,608

Underlying: Common Stock · 295,608 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in two equal installments on each of February 19, 2029 and February 19, 2030, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:51 UTC
Grigoryan GevorgChief Technology Officer
GrantStock Option (Right to Buy) · Derivative 196,368 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085886 · ownership.xml · derivative · entry 2

Grigoryan Gevorg · CIK 0002108976 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,368

Underlying: Common Stock · 196,368 shares

Expires 2036-02-25

F2 · derivative.exercise_date: The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:51 UTC
Grigoryan GevorgChief Technology Officer
GrantStock Option (Right to Buy) · Derivative 295,608 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001193125-26-085886 · ownership.xml · derivative · entry 1

Grigoryan Gevorg · CIK 0002108976 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,608

Underlying: Common Stock · 295,608 shares

Expires 2036-02-25

F1 · derivative.exercise_date: The shares underlying this option shall vest in two equal installments on each of February 19, 2029 and February 19, 2030, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.